Rhipicephalus (Boophilus) microplus (Arachnida: Ixodidae) larvae infestation of human eyelids. A rare case

Kaur, Navpreet, Prasher, Pawan, Kumar, Khushhal, Dhingra, Sakshi (2019): Rhipicephalus (Boophilus) microplus (Arachnida: Ixodidae) larvae infestation of human eyelids. A rare case. Acarologia 59 (1): 21-25, DOI: 10.24349/acarologia/20194309, URL: http://dx.doi.org/10.24349/acarologia/2019430

Figure 1 in Rhipicephalus (Boophilus) microplus (Arachnida: Ixodidae) larvae infestation of human eyelids. A rare case

Figure 1 Arrows showing the larvae ofRhipicephalus(B.) microplus attached to the upper eyelid of the right eye.Published as part of Kaur, Navpreet, Prasher, Pawan, Kumar, Khushhal & Dhingra, Sakshi, 2019, Rhipicephalus (Boophilus) microplus (Arachnida: Ixodidae) larvae infestation of human eyelids. A rare case, pp. 21-25 in Acarologia 59 (1) on page 22, DOI: 10.24349/acarologia/20194309, http://zenodo.org/record/450283

Figure 2 in Rhipicephalus (Boophilus) microplus (Arachnida: Ixodidae) larvae infestation of human eyelids. A rare case

Figure 2 Larvae of R. (B.) microplus.Published as part of Kaur, Navpreet, Prasher, Pawan, Kumar, Khushhal & Dhingra, Sakshi, 2019, Rhipicephalus (Boophilus) microplus (Arachnida: Ixodidae) larvae infestation of human eyelids. A rare case, pp. 21-25 in Acarologia 59 (1) on page 23, DOI: 10.24349/acarologia/20194309, http://zenodo.org/record/450283

A study of pulmonary function in end-stage renal disease patients on hemodialysis: a cross-sectional study

ABSTRACT BACKGROUND: The aim here was to study acute effects of hemodialysis among end-stage renal disease (ESRD) patients. DESIGN AND SETTING: Prospective study in tertiary-level care center. METHODS: Fifty ESRD patients undergoing hemodialysis were studied. Spirometric pulmonary function tests were performed before and after four-hour hemodialysis sessions. RESULTS: The patients’ average age was 45.8 ± 10.0 years; 64% were males and 64% had normal body mass index. Anemia (94%) and hypoalbuminemia (72%) were common. Diabetes mellitus (68%), hypertension (34%) and coronary artery disease (18%) were major comorbidities. Forty-five patients (90%) had been on hemodialysis for six months to three years. The patients’ pre-dialysis mean forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) were below normal: 45.8 ± 24.9% and 43.5 ± 25.9% of predicted, respectively. After hemodialysis, these increased significantly, to 51.1 ± 23.4% and 49.3 ± 25.5% of predicted, respectively (P 0.05). The pre-dialysis mean forced expiratory flow 25-75% was 50.1 ± 31% and increased significantly, to 56.3 ± 31.6% of predicted (P < 0.05). The mean peak expiratory flow was below normal (43.8 ± 30.7%) and increased significantly, to 49.1 ± 29.9% of predicted (P < 0.05). Males and females showed similar directions of change after hemodialysis. CONCLUSIONS: Pulmonary function abnormalities are common among ESRD patients. Comparison of pre and post-hemodialysis parameters showed significant improvements, but normal predicted values were still not achieved

A study of pulmonary function in end-stage renal disease patients on hemodialysis: a cross-sectional study

<div><p>ABSTRACT BACKGROUND: The aim here was to study acute effects of hemodialysis among end-stage renal disease (ESRD) patients. DESIGN AND SETTING: Prospective study in tertiary-level care center. METHODS: Fifty ESRD patients undergoing hemodialysis were studied. Spirometric pulmonary function tests were performed before and after four-hour hemodialysis sessions. RESULTS: The patients’ average age was 45.8 ± 10.0 years; 64% were males and 64% had normal body mass index. Anemia (94%) and hypoalbuminemia (72%) were common. Diabetes mellitus (68%), hypertension (34%) and coronary artery disease (18%) were major comorbidities. Forty-five patients (90%) had been on hemodialysis for six months to three years. The patients’ pre-dialysis mean forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) were below normal: 45.8 ± 24.9% and 43.5 ± 25.9% of predicted, respectively. After hemodialysis, these increased significantly, to 51.1 ± 23.4% and 49.3 ± 25.5% of predicted, respectively (P < 0.01). The increase in mean FEV1/FVC, from 97.8 ± 20.8% to 99.3 ± 20.1% of predicted, was not significant (P > 0.05). The pre-dialysis mean forced expiratory flow 25-75% was 50.1 ± 31% and increased significantly, to 56.3 ± 31.6% of predicted (P < 0.05). The mean peak expiratory flow was below normal (43.8 ± 30.7%) and increased significantly, to 49.1 ± 29.9% of predicted (P < 0.05). Males and females showed similar directions of change after hemodialysis. CONCLUSIONS: Pulmonary function abnormalities are common among ESRD patients. Comparison of pre and post-hemodialysis parameters showed significant improvements, but normal predicted values were still not achieved.</p></div